EGF antibody (AA 977-1023) (FITC)

Catalog No. ABIN7164294

The Rabbit Polyclonal anti-EGF antibody has been validated for . It is suitable to detect EGF in samples from Human.

Quick Overview for EGF antibody (AA 977-1023) (FITC) (ABIN7164294)

Target: EGF (Epidermal Growth Factor (EGF))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This EGF antibody is conjugated to FITC

Application: Please inquire

Product Details anti-EGF Antibody (FITC)

Binding Specificity: AA 977-1023

Cross-Reactivity: Human

Purification: >95%, Protein G purified

Immunogen: Recombinant Human Pro-epidermal growth factor protein (977-1023AA)

Isotype: IgG

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for EGF

Target: EGF (Epidermal Growth Factor (EGF))

Alternative Name: EGF

Background:

Background: EGF stimulates the growth of various epidermal andepithelial tissues in vivo and in vitro and of some fibroblasts in cell culture. Magnesiotropic hormone that stimulates magnesium reabsorption in the renal distal convoluted tubule via engagement of EGFR and activation of the magnesium channel TRPM6.

Aliases: Beta urogastrone antibody, beta-urogastrone antibody, EGF antibody, EGF_HUMAN antibody, Epidermal growth factor antibody, HOMG4 antibody, OTTHUMP00000219721 antibody, OTTHUMP00000219722 antibody, Pro epidermal growth factor antibody, URG antibody, Urogastrone antibody

UniProt: P01133

Pathways: NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation